Cerilliant Snap-N-Spike reference standards of designer psychedelics

Wednesday, 18 June, 2014 | Supplied by: Merck


Cerilliant has introduced six certified Snap-N-Spike reference standards of designer psychedelics in the NBOMe (N-methoxybenzyl-substituted) class of phenethylamines. The products include 25I-NBOMe HCl, 25C-NBOMe HCl and 25B-NBOMe HCl; and their deuterium labelled internal standards.

NBOMe phenethylamine derivatives represent a potentially lethal class of designer drugs with psychedelic and psychostimulant effects similar to LSD. Worldwide, increased production and sale of counterfeit hallucinogens laced with NBOMe derivatives have contributed to rising incidence of acute NBOMe toxicity. Regulatory agencies are responding to the threat posed by the harmful effects and growing use of the NBOMe designer drugs.

Cerilliant’s NBOMe reference standards complement their current offering of Certified Spiking Solutions for phenethylamines and their internal standards including the 2C amines, dibenzofurans and D amphetamines. Since these compounds are classified as controlled substances, the company supplies its Certified Spiking Solutions of NBOMe phenethylamines in a convenient, quantitative, USDEA and Health Canada (with TK#s)-exempt solution.

The reference standards are manufactured and certified to industry standards including ISO Guide 34, ISO/IEC 17025 and ISO 13485. They are suitable for a wide variety of quantitative or qualitative applications: from control or calibrator preparation in forensic analysis or clinical toxicology testing, to urine drug analysis and isotope dilution methods.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers

The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...

RevMAb Biosciences histone family protein monoclonal antibodies

RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd